Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Synergy CHC

OTCPK:SNYR
Snowflake Description

Fair value with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SNYR
OTCPK
$6M
Market Cap
  1. Home
  2. US
  3. Household
Company description

Synergy CHC Corp., a consumer health care company, markets and distributes various consumer branded products primarily in the health and wellness industry in North America. The last earnings update was 147 days ago. More info.


Add to Portfolio Compare Print
  • Synergy CHC has significant price volatility in the past 3 months.
SNYR Share Price and Events
7 Day Returns
2.9%
OTCPK:SNYR
11.5%
US Personal Products
8%
US Market
1 Year Returns
-52%
OTCPK:SNYR
-14.7%
US Personal Products
-8.1%
US Market
SNYR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Synergy CHC (SNYR) 2.9% 44% 2.3% -52% -80.8% -79.4%
US Personal Products 11.5% -13% -24.8% -14.7% 22.5% 7.5%
US Market 8% -4.5% -17.8% -8.1% 13.2% 23.7%
1 Year Return vs Industry and Market
  • SNYR underperformed the Personal Products industry which returned -14.7% over the past year.
  • SNYR underperformed the Market in United States of America which returned -8.1% over the past year.
Price Volatility
SNYR
Industry
5yr Volatility vs Market

SNYR Value

 Is Synergy CHC undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Synergy CHC to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Synergy CHC.

OTCPK:SNYR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 7.9%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:SNYR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.682 (1 + (1- 21%) (95.61%))
1.132
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.13
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (1.132 * 5.44%)
7.9%

Discounted Cash Flow Calculation for OTCPK:SNYR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Synergy CHC is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

OTCPK:SNYR DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.9%)
2020 2.16 Est @ 70.2% 2.00
2021 3.23 Est @ 49.66% 2.77
2022 4.37 Est @ 35.29% 3.48
2023 5.47 Est @ 25.22% 4.04
2024 6.47 Est @ 18.18% 4.42
2025 7.32 Est @ 13.25% 4.64
2026 8.04 Est @ 9.79% 4.72
2027 8.63 Est @ 7.38% 4.70
2028 9.12 Est @ 5.69% 4.60
2029 9.53 Est @ 4.5% 4.46
Present value of next 10 years cash flows $39.00
OTCPK:SNYR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $9.53 × (1 + 1.74%) ÷ (7.9% – 1.74%)
$157.51
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $157.51 ÷ (1 + 7.9%)10
$73.65
OTCPK:SNYR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $39.00 + $73.65
$112.65
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $112.65 / 89.89
$1.25
OTCPK:SNYR Discount to Share Price
Calculation Result
Value per share (USD) From above. $1.25
Current discount Discount to share price of $0.07
= -1 x ($0.07 - $1.25) / $1.25
94.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Synergy CHC is available for.
Intrinsic value
>50%
Share price is $0.07 vs Future cash flow value of $1.25
Current Discount Checks
For Synergy CHC to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Synergy CHC's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Synergy CHC's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Synergy CHC's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Synergy CHC's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:SNYR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $-0.04
OTCPK:SNYR Share Price ** OTCPK (2020-04-08) in USD $0.07
United States of America Personal Products Industry PE Ratio Median Figure of 18 Publicly-Listed Personal Products Companies 11.3x
United States of America Market PE Ratio Median Figure of 2,949 Publicly-Listed Companies 13.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Synergy CHC.

OTCPK:SNYR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:SNYR Share Price ÷ EPS (both in USD)

= 0.07 ÷ -0.04

-1.71x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Synergy CHC is loss making, we can't compare its value to the US Personal Products industry average.
  • Synergy CHC is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Synergy CHC's expected growth come at a high price?
Raw Data
OTCPK:SNYR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.71x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Personal Products Industry PEG Ratio Median Figure of 6 Publicly-Listed Personal Products Companies 1.61x
United States of America Market PEG Ratio Median Figure of 2,009 Publicly-Listed Companies 0.9x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Synergy CHC, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Synergy CHC's assets?
Raw Data
OTCPK:SNYR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $0.07
OTCPK:SNYR Share Price * OTCPK (2020-04-08) in USD $0.07
United States of America Personal Products Industry PB Ratio Median Figure of 42 Publicly-Listed Personal Products Companies 1.85x
United States of America Market PB Ratio Median Figure of 5,163 Publicly-Listed Companies 1.29x
OTCPK:SNYR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:SNYR Share Price ÷ Book Value per Share (both in USD)

= 0.07 ÷ 0.07

1.09x

* Primary Listing of Synergy CHC.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Synergy CHC is good value based on assets compared to the US Personal Products industry average.
X
Value checks
We assess Synergy CHC's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Synergy CHC has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SNYR Future Performance

 How is Synergy CHC expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Synergy CHC has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.8%
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Synergy CHC expected to grow at an attractive rate?
  • Unable to compare Synergy CHC's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Synergy CHC's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Synergy CHC's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:SNYR Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 21.8%
United States of America Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 5.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 6.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:SNYR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:SNYR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 28 2 -4
2019-06-30 30 2 -4
2019-03-31 34 1 -5
2018-12-31 34 1 -6
2018-09-30 35 0 -3
2018-06-30 35 -3 -3
2018-03-31 35 -2 -2
2017-12-31 36 -1 0
2017-09-30 36 1 -4
2017-06-30 38 6 -1
2017-03-31 37 4 -1
2016-12-31 35 6 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Synergy CHC is high growth as no earnings estimate data is available.
  • Unable to determine if Synergy CHC is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:SNYR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Synergy CHC Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SNYR Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 -0.04
2019-06-30 -0.04
2019-03-31 -0.05
2018-12-31 -0.07
2018-09-30 -0.03
2018-06-30 -0.03
2018-03-31 -0.02
2017-12-31 0.01
2017-09-30 -0.05
2017-06-30 -0.01
2017-03-31 -0.01
2016-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Synergy CHC will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Synergy CHC is trading at Synergy CHC'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Synergy CHC's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Synergy CHC's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Synergy CHC's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Synergy CHC has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SNYR Past Performance

  How has Synergy CHC performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Synergy CHC's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Synergy CHC does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Synergy CHC's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Synergy CHC's 1-year growth to the US Personal Products industry average as it is not currently profitable.
Earnings and Revenue History
Synergy CHC's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Synergy CHC Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SNYR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 28.37 -3.77 18.46
2019-06-30 30.20 -3.54 19.40
2019-03-31 33.59 -4.64 22.31
2018-12-31 33.82 -6.16 23.52
2018-09-30 34.93 -2.63 23.15
2018-06-30 34.92 -2.85 23.67
2018-03-31 34.51 -2.11 23.64
2017-12-31 35.60 0.50 22.46
2017-09-30 36.01 -4.01 23.41
2017-06-30 38.41 -1.09 22.60
2017-03-31 37.36 -1.05 19.87
2016-12-31 34.84 -0.80 18.35
2016-09-30 34.33 1.38 15.47
2016-06-30 25.94 -2.13 12.12
2016-03-31 20.12 -2.31 9.32
2015-12-31 13.46 -7.54 7.05
2015-09-30 7.24 -3.25 3.70
2015-06-30 4.06 -2.92 2.32
2015-03-31 1.61 -3.38 1.90
2014-12-31 0.01 -0.96 0.85
2014-09-30 0.00 -0.82 0.82
2014-06-30 0.00 -0.70 0.70
2014-03-31 -0.06 0.06
2014-01-31 -0.04 0.04
2013-12-31 -0.06 0.06
2013-10-31 -0.03 0.03
2013-07-31 -0.02 0.02

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Synergy CHC has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Synergy CHC has efficiently used its assets last year compared to the US Personal Products industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Synergy CHC improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Synergy CHC's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Synergy CHC has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SNYR Health

 How is Synergy CHC's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Synergy CHC's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Synergy CHC's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Synergy CHC's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Synergy CHC's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Synergy CHC Company Filings, last reported 6 months ago.

OTCPK:SNYR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 5.93 6.19 1.40
2019-06-30 5.73 6.66 1.07
2019-03-31 5.45 7.13 0.69
2018-12-31 3.97 7.59 0.46
2018-09-30 9.17 8.05 1.61
2018-06-30 8.94 8.46 0.87
2018-03-31 9.56 8.93 1.69
2017-12-31 9.43 9.95 1.96
2017-09-30 10.95 11.64 5.41
2017-06-30 10.51 3.62 0.89
2017-03-31 10.00 5.17 1.71
2016-12-31 7.11 7.47 2.52
2016-09-30 11.00 7.63 4.22
2016-06-30 7.71 8.56 3.01
2016-03-31 8.53 8.91 3.76
2015-12-31 5.42 9.49 3.64
2015-09-30 1.85 6.85 0.82
2015-06-30 0.81 6.93 0.64
2015-03-31 0.98 6.18 1.72
2014-12-31 -0.13 0.11 0.00
2014-09-30 0.04 0.01 0.01
2014-06-30 0.16 0.02 0.19
2014-03-31 -0.01 0.00 0.00
2014-01-31 -0.02 0.01 0.00
2013-12-31 -0.01 0.00 0.00
2013-10-31 0.00 0.02 0.03
2013-07-31 0.01 0.00 0.03
  • Synergy CHC's level of debt (104.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (36.1% vs 104.4% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Synergy CHC has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Synergy CHC has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -5.6% per year.
X
Financial health checks
We assess Synergy CHC's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Synergy CHC has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SNYR Dividends

 What is Synergy CHC's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Synergy CHC dividends.
If you bought $2,000 of Synergy CHC shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Synergy CHC's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Synergy CHC's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:SNYR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 8 Stocks 1.9%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1933 Stocks 2.8%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.9%
United States of America Top 25% Dividend Yield 75th Percentile 5.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Synergy CHC has not reported any payouts.
  • Unable to verify if Synergy CHC's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Synergy CHC's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Synergy CHC has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Synergy CHC's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Synergy CHC afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Synergy CHC has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SNYR Management

 What is the CEO of Synergy CHC's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jack Ross
COMPENSATION $0
AGE 53
TENURE AS CEO 5.5 years
CEO Bio

Mr. Jack Ross has been the Chairman and Chief Executive Officer at Synergy CHC Corp. since October 27, 2014 and its Chief Financial Officer since August 17, 2018. Mr. Ross served as Chief Financial Officer and Chief Accounting Officer at Synergy CHC Corp. from October 27, 2014 to 2017 and served as its President until October 2017 and also served as its Secretary and Treasurer until 2017. Mr. Ross has been an Officer and Director of Pure Sports Inc. since February 2009, the sole officer and Director of Gowan Capital Inc., since May 2011, Officer and Director of Synergy Energy Strips World Wide Inc., since August 2011, the sole officer and director of Rio e Cigs Inc. since December 2011 and the sole officer and director of Kenek Brands Inc. since May 2014. From January 2012 to April 2014, Mr. Ross served as the sole officer and director of Synergy Strips Corp., which was acquired by and became a wholly owned subsidiary of the Company in April 2014 (the “Subsidiary”) in connection with the Merger. Other than the Subsidiary, none of these companies are related to or affiliated with the Company.

CEO Compensation
  • Insufficient data for Jack to compare compensation growth.
  • Insufficient data for Jack to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure of the Synergy CHC management team in years:

4.7
Average Tenure
  • The tenure for the Synergy CHC management team is about average.
Management Team

Jack Ross

TITLE
Chairman
AGE
53
TENURE
5.5 yrs

Patrick McCullough

TITLE
President
COMPENSATION
$337K
AGE
54
TENURE
2.5 yrs

Jaime Fickett

TITLE
Senior Vice President of Finance & Operations

Al Baumeler

TITLE
Executive Vice President of Sales & Marketing - Retail
TENURE
4.7 yrs
Board of Directors Tenure

Average tenure and age of the Synergy CHC board of directors in years:

5.3
Average Tenure
67.5
Average Age
  • The tenure for the Synergy CHC board of directors is about average.
Board of Directors

Jack Ross

TITLE
Chairman
AGE
53
TENURE
5.5 yrs

Stephen Fryer

TITLE
Independent Director
COMPENSATION
$5K
AGE
80
TENURE
5.3 yrs

James SoRelle

TITLE
Independent Director
AGE
63
TENURE
5.3 yrs

Gale Bensussen

TITLE
Independent Director
AGE
72
TENURE
2.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
21. Jan 20 Buy Gowan Capital, Inc. Company 21. Jan 20 21. Jan 20 228,572 $0.04 $9,989
X
Management checks
We assess Synergy CHC's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Synergy CHC has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SNYR News

Simply Wall St News

SNYR Company Info

Description

Synergy CHC Corp., a consumer health care company, markets and distributes various consumer branded products primarily in the health and wellness industry in North America. The company offers FOCUSfactor, a brain-health nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals, antioxidants, and other nutrients; Flat Tummy Tea, a two-step herbal detox tea that works to help speed metabolism, boost energy, and reduce bloating; and Hand MD, an anti-aging skincare line formulated for the hands. It also provides Neuragen, a topical product that works directly at the site of the pain as opposed to oral products; Sneaky Vaunt, a backless, strapless, stick on, and push up bra; The Queen Pegasus, a two-step eyelash elixir kit for natural eyelashes; Per-fekt Beauty line of cosmetics; and Think Fuel, a nootropic supplement for enhance brain function. Synergy CHC Corp. sells its products directly to wholesalers and distributors; and online through flattummyco.com, sneakyvaunt.com, thequeenpegasus.com, perfektbeauty.com, and www.thinkfuel.com, as well as through retail distribution channels. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was founded in 2012 and is based in Westbrook, Maine.

Details
Name: Synergy CHC Corp.
SNYR
Exchange: OTCPK
Founded: 2012
$6,472,013
89,889,074
Website: http://www.synergychc.com
Address: Synergy CHC Corp.
865 Spring Street,
Westbrook,
Maine, 04092,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK SNYR New Common Stock Pink Sheets LLC US USD 25. Apr 2014
Number of employees
Current staff
Staff numbers
43
Synergy CHC employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/09 04:37
End of day share price update: 2020/04/08 00:00
Last earnings filing: 2019/11/14
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.